Skip to main content
Top
Published in: BMC Geriatrics 1/2013

Open Access 01-12-2013 | Research article

Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study

Authors: Antje Kuhlmann, Inga Sif Ólafsdóttir, Lars Lind, Johan Sundström, Christer Janson

Published in: BMC Geriatrics | Issue 1/2013

Login to get access

Abstract

Background

Low lung function is associated with increased morbidity and mortality. It is therefore of interest to identify biomarkers that are associated with impaired lung function. The aim of the study was to analyse associations of biomarkers and combinations of biomarkers with lung function in an elderly general population.

Methods

Lung function (FEV1 and FVC) and a panel of 15 inflammatory markers from blood samples were analysed in 888 subjects aged 70 years. Biomarkers included cytokines, chemokines, adhesion molecules, C-reactive protein (CRP) and leukocyte count.

Results

Leukocyte count and CRP were independently associated with FEV1 after adjustments for other inflammatory markers, sex, BMI, current smoking and pack-years of smoking. In a similar model, leukocyte count and vascular cell adhesion protein 1 (VCAM-1) were the biomarkers that were significantly associated with FVC. Subjects that had both leukocyte count and CRP in the lowest tertile had a FEV1 that was 9% of predicted higher than subjects with leukocyte count and CRP in the highest tertile (103±16 vs. 94±21% of predicted, p=0.0002) (mean±SD). A difference of 8% of predicted in FVC was found between subjects with leukocyte count and VCAM-1 in the lowest and highest tertiles, respectively (106±18 vs. 98±19% of predicted, p=0.002).

Conclusion

Leucocyte count, CRP and VCAM-1 were found to relate to poorer lung function. A dose related association was found for the combination leukocyte count and CRP towards FEV1 and leukocyte and VCAM-1 towards FVC. This indicates that combination of two biomarkers yielded more information than assessing them one by one when analysing the association between systemic inflammation and lung function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ: Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol. 1982, 116: 102-113.PubMed Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ: Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol. 1982, 116: 102-113.PubMed
2.
go back to reference Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M: Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991, 4: 1080-1087.PubMed Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M: Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991, 4: 1080-1087.PubMed
3.
go back to reference Engström G, Janzon L: Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med. 2002, 19: 167-170.CrossRefPubMed Engström G, Janzon L: Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med. 2002, 19: 167-170.CrossRefPubMed
4.
go back to reference Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F: Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002, 106: 2555-2560. 10.1161/01.CIR.0000037220.00065.0D.CrossRefPubMed Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F: Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002, 106: 2555-2560. 10.1161/01.CIR.0000037220.00065.0D.CrossRefPubMed
5.
go back to reference Margretardottir OB, Thorleifsson SJ, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gíslason T: Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study. COPD. 2009, 6: 250-255. 10.1080/15412550903049157.CrossRefPubMedPubMedCentral Margretardottir OB, Thorleifsson SJ, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gíslason T: Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study. COPD. 2009, 6: 250-255. 10.1080/15412550903049157.CrossRefPubMedPubMedCentral
6.
go back to reference Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group: The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail. 2010, 12: 685-691. 10.1093/eurjhf/hfq050.CrossRefPubMed Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group: The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail. 2010, 12: 685-691. 10.1093/eurjhf/hfq050.CrossRefPubMed
7.
go back to reference Burney PGJ, Hooper R: Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011, 66: 49-54. 10.1136/thx.2010.147041.CrossRefPubMed Burney PGJ, Hooper R: Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011, 66: 49-54. 10.1136/thx.2010.147041.CrossRefPubMed
8.
go back to reference Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M, Marmot MG, Kivimäki M: Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol. 2011, 26: 135-144. 10.1007/s10654-010-9526-5.CrossRefPubMedPubMedCentral Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M, Marmot MG, Kivimäki M: Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol. 2011, 26: 135-144. 10.1007/s10654-010-9526-5.CrossRefPubMedPubMedCentral
9.
go back to reference Mannino DM, Valvi D, Mullerova H, Tal-Singer R: Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD. 2012, 9: 359-366.CrossRefPubMed Mannino DM, Valvi D, Mullerova H, Tal-Singer R: Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD. 2012, 9: 359-366.CrossRefPubMed
10.
go back to reference Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.CrossRefPubMedPubMedCentral Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.CrossRefPubMedPubMedCentral
11.
go back to reference Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O’Connor GT, Benjamin EJ: Systemic inflammation and COPD: the Framingham heart study. Chest. 2008, 133: 19-25. 10.1378/chest.07-0058.CrossRefPubMed Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O’Connor GT, Benjamin EJ: Systemic inflammation and COPD: the Framingham heart study. Chest. 2008, 133: 19-25. 10.1378/chest.07-0058.CrossRefPubMed
12.
go back to reference Gan WQ, Man SFP, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004, 59: 574-580. 10.1136/thx.2003.019588.CrossRefPubMedPubMedCentral Gan WQ, Man SFP, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004, 59: 574-580. 10.1136/thx.2003.019588.CrossRefPubMedPubMedCentral
13.
go back to reference Chang SS, Vaz Fragoso CA, Van Ness PH, Fried LP, Tinetti ME: Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women’s Health and Aging Studies I and II. J Am Geriatr Soc. 2011, 59: 113-119. 10.1111/j.1532-5415.2010.03203.x.CrossRefPubMedPubMedCentral Chang SS, Vaz Fragoso CA, Van Ness PH, Fried LP, Tinetti ME: Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women’s Health and Aging Studies I and II. J Am Geriatr Soc. 2011, 59: 113-119. 10.1111/j.1532-5415.2010.03203.x.CrossRefPubMedPubMedCentral
14.
go back to reference Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, Macnee W, Rennard S, Silverman E, Vestbo J, Wouters E, Agustí A, ECLIPSE Investigators: Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 1065-1072. 10.1164/rccm.201110-1792OC.CrossRefPubMed Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, Macnee W, Rennard S, Silverman E, Vestbo J, Wouters E, Agustí A, ECLIPSE Investigators: Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 1065-1072. 10.1164/rccm.201110-1792OC.CrossRefPubMed
15.
go back to reference Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG: Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186: 982-988. 10.1164/rccm.201206-1113OC.CrossRefPubMed Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG: Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186: 982-988. 10.1164/rccm.201206-1113OC.CrossRefPubMed
16.
go back to reference Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gíslason T: Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med. 2009, 103: 1548-1553. 10.1016/j.rmed.2009.04.005.CrossRefPubMedPubMedCentral Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gíslason T: Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med. 2009, 103: 1548-1553. 10.1016/j.rmed.2009.04.005.CrossRefPubMedPubMedCentral
17.
go back to reference Olafsdóttir IS, Gíslason T, Thjódleifsson B, Olafsson I, Gíslason D, Jõgi R, Janson C: Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2: 635-642.PubMedPubMedCentral Olafsdóttir IS, Gíslason T, Thjódleifsson B, Olafsson I, Gíslason D, Jõgi R, Janson C: Gender differences in the association between C-reactive protein, lung function impairment, and COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2: 635-642.PubMedPubMedCentral
18.
go back to reference Olafsdóttir IS, Janson C, Lind L, Hulthe J, Gunnbjörnsdóttir M, Sundström J: Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: a population-based study. Respirology. 2010, 15: 530-535. 10.1111/j.1440-1843.2010.01718.x.CrossRefPubMed Olafsdóttir IS, Janson C, Lind L, Hulthe J, Gunnbjörnsdóttir M, Sundström J: Serum levels of matrix metalloproteinase-9, tissue inhibitors of metalloproteinase-1 and their ratio are associated with impaired lung function in the elderly: a population-based study. Respirology. 2010, 15: 530-535. 10.1111/j.1440-1843.2010.01718.x.CrossRefPubMed
19.
go back to reference Olafsdóttir IS, Gíslason T, Gudnason V, Benediktsdottir B, Olafsson I, Aspelund T, Thjódleifsson B, Janson C: CRP is associated with lung function decline in men but not women: a prospective study. Respir Med. 2013, 107: 91-97. 10.1016/j.rmed.2012.09.020.CrossRefPubMed Olafsdóttir IS, Gíslason T, Gudnason V, Benediktsdottir B, Olafsson I, Aspelund T, Thjódleifsson B, Janson C: CRP is associated with lung function decline in men but not women: a prospective study. Respir Med. 2013, 107: 91-97. 10.1016/j.rmed.2012.09.020.CrossRefPubMed
20.
go back to reference Lind L, Fors N, Hall J, Marttala K, Stenborg A: A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol. 2005, 25: 2368-2375. 10.1161/01.ATV.0000184769.22061.da.CrossRefPubMed Lind L, Fors N, Hall J, Marttala K, Stenborg A: A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol. 2005, 25: 2368-2375. 10.1161/01.ATV.0000184769.22061.da.CrossRefPubMed
21.
go back to reference Engström G, Gerhardsson de Verdier M, Dahlbäck M, Janson C, Lind L: BP variability and cardiovascular autonomic function in relation to forced expiratory volume: a population-based study. Chest. 2009, 136: 177-183. 10.1378/chest.08-2529.CrossRefPubMed Engström G, Gerhardsson de Verdier M, Dahlbäck M, Janson C, Lind L: BP variability and cardiovascular autonomic function in relation to forced expiratory volume: a population-based study. Chest. 2009, 136: 177-183. 10.1378/chest.08-2529.CrossRefPubMed
22.
go back to reference Anon: Standardization of spirometry, 1994 update: American Thoracic society. Am J Respir Crit Care Med. 1995, 152: 1107-1136.CrossRef Anon: Standardization of spirometry, 1994 update: American Thoracic society. Am J Respir Crit Care Med. 1995, 152: 1107-1136.CrossRef
23.
go back to reference Anon: Standardisation of lung function tests: European community for coal steel. Clin Respir Phys. 1983, 19 (Suppl 5): 22-27. Anon: Standardisation of lung function tests: European community for coal steel. Clin Respir Phys. 1983, 19 (Suppl 5): 22-27.
24.
go back to reference Lind L, Siegbahn A, Hulthe J, Elmgren A: C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. Atherosclerosis. 2008, 199: 129-137. 10.1016/j.atherosclerosis.2007.09.038.CrossRefPubMed Lind L, Siegbahn A, Hulthe J, Elmgren A: C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. Atherosclerosis. 2008, 199: 129-137. 10.1016/j.atherosclerosis.2007.09.038.CrossRefPubMed
25.
go back to reference Fitzgerald SP, McConnell RI, Huxley A: Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array. J Proteome Res. 2008, 7: 450-455. 10.1021/pr070409o.CrossRefPubMed Fitzgerald SP, McConnell RI, Huxley A: Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array. J Proteome Res. 2008, 7: 450-455. 10.1021/pr070409o.CrossRefPubMed
26.
go back to reference Cazzola M, Novelli G: Biomarkers in COPD. Pulm Pharmacol Ther. 2010, 23: 493-500. 10.1016/j.pupt.2010.05.001.CrossRefPubMed Cazzola M, Novelli G: Biomarkers in COPD. Pulm Pharmacol Ther. 2010, 23: 493-500. 10.1016/j.pupt.2010.05.001.CrossRefPubMed
27.
go back to reference Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J, EPI-SCAN Steering Committee: Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010, 11: 63-10.1186/1465-9921-11-63.CrossRefPubMedPubMedCentral Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J, EPI-SCAN Steering Committee: Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010, 11: 63-10.1186/1465-9921-11-63.CrossRefPubMedPubMedCentral
28.
go back to reference Donaldson GC, Seemungal TAR, Patel IS, Bhowmik A, Wilkinson TMA, Hurst JR, MacCallum PK, Wedzicha JA: Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005, 128: 1995-2004. 10.1378/chest.128.4.1995.CrossRefPubMed Donaldson GC, Seemungal TAR, Patel IS, Bhowmik A, Wilkinson TMA, Hurst JR, MacCallum PK, Wedzicha JA: Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005, 128: 1995-2004. 10.1378/chest.128.4.1995.CrossRefPubMed
29.
go back to reference Chan-Yeung M, Abboud R, Buncio AD, Vedal S: Peripheral leucocyte count and longitudinal decline in lung function. Thorax. 1988, 43: 462-466. 10.1136/thx.43.6.462.CrossRefPubMedPubMedCentral Chan-Yeung M, Abboud R, Buncio AD, Vedal S: Peripheral leucocyte count and longitudinal decline in lung function. Thorax. 1988, 43: 462-466. 10.1136/thx.43.6.462.CrossRefPubMedPubMedCentral
30.
go back to reference Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y: Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009, 103: 1231-1238. 10.1016/j.rmed.2009.01.021.CrossRefPubMed Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y: Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009, 103: 1231-1238. 10.1016/j.rmed.2009.01.021.CrossRefPubMed
31.
go back to reference Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S: Analysis of systemic biomarkers in COPD patients. COPD. 2004, 1: 155-164. 10.1081/COPD-120030828.CrossRefPubMed Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S: Analysis of systemic biomarkers in COPD patients. COPD. 2004, 1: 155-164. 10.1081/COPD-120030828.CrossRefPubMed
32.
go back to reference Janson C, Ludviksdottir D, Gunnbjörnsdóttir M, Björnsson EH, Håkansson L, Venge P, BHR-study group: Circulating adhesion molecules in allergic and non-allergic asthma. Respir Med. 2005, 99: 45-51. 10.1016/j.rmed.2004.05.007.CrossRefPubMed Janson C, Ludviksdottir D, Gunnbjörnsdóttir M, Björnsson EH, Håkansson L, Venge P, BHR-study group: Circulating adhesion molecules in allergic and non-allergic asthma. Respir Med. 2005, 99: 45-51. 10.1016/j.rmed.2004.05.007.CrossRefPubMed
33.
go back to reference Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM: Systemic effects of smoking. Chest. 2007, 131: 1557-1566. 10.1378/chest.06-2179.CrossRefPubMed Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM: Systemic effects of smoking. Chest. 2007, 131: 1557-1566. 10.1378/chest.06-2179.CrossRefPubMed
34.
go back to reference Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 282: 2131-2135. 10.1001/jama.282.22.2131.CrossRefPubMed Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 282: 2131-2135. 10.1001/jama.282.22.2131.CrossRefPubMed
35.
go back to reference Di Napoli M, Godoy DA, Campi V, Masotti L, Smith CJ, Parry Jones AR, Hopkins SJ, Slevin M, Papa F, Mogoanta L, Pirici D, Wagner AP: C-reactive protein in intracerebral hemorrhage. Neurology. 2012, 79: 690-699. 10.1212/WNL.0b013e318264e3be.CrossRefPubMed Di Napoli M, Godoy DA, Campi V, Masotti L, Smith CJ, Parry Jones AR, Hopkins SJ, Slevin M, Papa F, Mogoanta L, Pirici D, Wagner AP: C-reactive protein in intracerebral hemorrhage. Neurology. 2012, 79: 690-699. 10.1212/WNL.0b013e318264e3be.CrossRefPubMed
36.
go back to reference Danesh J, Wheeler JG, Hirschfield GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350: 1387-97. 10.1056/NEJMoa032804.CrossRefPubMed Danesh J, Wheeler JG, Hirschfield GM, et al: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004, 350: 1387-97. 10.1056/NEJMoa032804.CrossRefPubMed
37.
go back to reference Cote CG, Chapman KR: Diagnosis and treatment considerations for women with COPD. Int J Clin Pract. 2009, 63: 486-493. 10.1111/j.1742-1241.2008.01987.x.CrossRefPubMed Cote CG, Chapman KR: Diagnosis and treatment considerations for women with COPD. Int J Clin Pract. 2009, 63: 486-493. 10.1111/j.1742-1241.2008.01987.x.CrossRefPubMed
38.
go back to reference Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, Hogg J, Ries AL, Han M, Fishman AP, Make B, Hoffman EA, Mohsenifar Z, Wise R: National emphysema treatment trial research group: sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007, 176: 243-252. 10.1164/rccm.200606-828OC.CrossRefPubMedPubMedCentral Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, Hogg J, Ries AL, Han M, Fishman AP, Make B, Hoffman EA, Mohsenifar Z, Wise R: National emphysema treatment trial research group: sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007, 176: 243-252. 10.1164/rccm.200606-828OC.CrossRefPubMedPubMedCentral
Metadata
Title
Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study
Authors
Antje Kuhlmann
Inga Sif Ólafsdóttir
Lars Lind
Johan Sundström
Christer Janson
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2013
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-13-82

Other articles of this Issue 1/2013

BMC Geriatrics 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.